Kentaro Ebisu

Title: Kentaro Ebisu: Innovator in Blood Coagulation Factor Collection

Introduction

Kentaro Ebisu is a notable inventor based in Koshi, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of blood coagulation factor collection. With a total of 2 patents to his name, his work has the potential to impact medical practices significantly.

Latest Patents

One of Kentaro Ebisu's latest patents is a chromatographic method for collecting blood coagulation factor VII with high yield. This innovative method allows for the collection of Factor VII and/or activated Factor VII from plasma-derived fractions with a recovery rate of 90% or more. The process involves letting Factor VII and/or activated Factor VII, which fails to be adsorbed to a first anion exchange resin, be adsorbed in a second anion exchange resin. This advancement in methodology enhances the efficiency of collecting vital blood components.

Career Highlights

Kentaro Ebisu is currently associated with Km Biologics Co., Ltd., where he continues to develop and refine his innovative techniques. His work is crucial in advancing the understanding and application of blood coagulation factors in medical treatments.

Collaborations

Kentaro has collaborated with notable coworkers, including Takashi Kai and Nozomi Matsuo. Their combined expertise contributes to the success of their projects and the advancement of their research.

Conclusion

Kentaro Ebisu's contributions to the field of blood coagulation factor collection exemplify the importance of innovation in biotechnology. His patented methods not only enhance recovery rates but also pave the way for improved medical applications.